Medicine and Dentistry
Transitional Cell Carcinoma
100%
Neoplasm
66%
Prostate Cancer
61%
Nephroureterectomy
54%
Bladder Cancer
48%
Diseases
41%
Recurrent Disease
40%
Malignant Neoplasm
38%
Bladder
36%
Biopsy Technique
32%
Clear Cell Renal Cell Carcinoma
30%
Nephrectomy
26%
Prostatectomy
25%
Kidney Stone
24%
Partial Nephrectomy
24%
Kidney Tumour
22%
Surgery
21%
Surgeon
20%
Cystectomy
20%
Pelvis
19%
Urology
18%
Robot-Assisted Prostatectomy
18%
Percutaneous Nephrolithotomy
18%
Urologist
16%
Cancer Specific Survival
16%
Cancer
15%
Kidney Function
14%
Retroperitoneal Lymph Node Dissection
14%
Lymph Node
14%
Operation Duration
14%
Prostate Specific Antigen
14%
Quality of Life
13%
Overall Survival
13%
Hazard Ratio
13%
Bleeding
13%
Health Care Cost
12%
Prostate Biopsy
12%
Non Muscle Invasive Bladder Cancer
12%
Metastatic Carcinoma
12%
Body Mass Index
12%
Radical Nephrectomy
12%
Magnetic Resonance Imaging
12%
Glomerular Filtration Rate
11%
Pyeloplasty
11%
Lithotripsy
11%
Hypospadia
10%
Pediatrics
10%
Diagnosis
10%
Transrectal Ultrasonography
10%
Urothelial Cancer
10%
Odds Ratio
10%
Disease
9%
Upper Urinary Tract
9%
Urinary System
9%
Needle Biopsy
9%
Laparoscopic Surgery
9%
Neoadjuvant Chemotherapy
9%
Recurrence Free Survival
9%
Ureteroscopy
9%
Surgical Technique
8%
Computer Assisted Tomography
8%
Microhematuria
8%
Proportional Hazards Model
8%
Transurethral Resection
8%
Hydronephrosis
8%
Ureter Stone
8%
Radiofrequency Ablation
8%
Biological Marker
8%
Kidney Cancer
7%
Incision
7%
Lymphovascular Invasion
7%
Robot-Assisted Surgery
7%
Urinary Tract Infection
7%
Cisplatin
7%
Cancer Staging
7%
Fistula
7%
Cancer Diagnosis
6%
Urodynamics
6%
Systematic Review
6%
Infection
6%
Risk Stratification
6%
Logistic Regression Analysis
6%
Muscle Invasive Bladder Cancer
6%
Radiation Therapy
6%
Lymph Node Metastasis
6%
Postoperative Complication
6%
Continence
6%
Nephrolithotomy
6%
Ureter
6%
Chronic Kidney Disease
6%
Cryoablation
6%
Gleason Score
6%
Multivariate Analysis
5%
Urethroplasty
5%
Adrenalectomy
5%
Lower Urinary Tract Symptom
5%
Neurogenic Bladder
5%
Adjuvant Chemotherapy
5%
Extracorporeal Shock Wave Lithotripsy
5%
Arm
5%
Keyphrases
Upper Tract Urothelial Carcinoma
79%
Nephroureterectomy
48%
Bladder Cancer
42%
Prostate Cancer
41%
Renal Cell Carcinoma
23%
Tumor
23%
Oncological Outcomes
22%
Cancer-specific Survival
16%
Bladder
16%
Urologists
14%
Hazard Ratio
14%
Partial Nephrectomy
13%
Percutaneous Nephrolithotomy
13%
High Risk
13%
United States
12%
Nephrectomy
12%
Confidence Interval
12%
Postoperative Outcomes
12%
Radical Prostatectomy
12%
Body Mass Index
12%
Recurrent Disease
11%
Overall Survival
11%
Non-muscle Invasive Bladder Cancer (NMIBC)
11%
Urology
11%
Robot-assisted Radical Prostatectomy
11%
Radical Cystectomy
11%
Kidney Stones
10%
Prostate-specific Antigen
10%
Urothelial Carcinoma
10%
Radical Nephrectomy
10%
Kidney
9%
Renal Function
9%
Multivariable
9%
Multi-institutional
9%
Prostate
9%
Forkhead Box A1 (FOXA1)
9%
Laparoscopic Partial Nephrectomy
9%
Operative Time
9%
Clinical Outcomes
9%
Cancer Mortality
9%
Renal Mass
8%
Risk Factors
8%
Surgeons
8%
Neoadjuvant Chemotherapy
8%
Minimally Invasive
8%
Small Renal Mass
8%
Chemotherapy
8%
Metastatic Renal Cell Carcinoma (mRCC)
8%
Odds Ratio
7%
Muscle-invasive Bladder Cancer
7%
Lymphovascular Invasion
7%
Prostate Cancer Screening
7%
Urologic
7%
Pediatric
7%
Health-related Quality of Life
7%
Ureter
7%
Hematuria
7%
Recurrence-free Survival
7%
Quality of Life
7%
Estimated Glomerular Filtration Rate
7%
Nomogram
7%
Active Surveillance
7%
Radiofrequency Ablation
6%
Upper Tract
6%
Multiparametric MRI (mpMRI)
6%
Functional Outcome
6%
Urology Residents
6%
Pathological Stage
6%
Stone Disease
6%
Prostate Needle Biopsy
6%
Tumor Grade
6%
Tumor Size
6%
Comparative Analysis
6%
Transrectal Ultrasound
6%
Prostate Biopsy
6%
Robotics
6%
Prognostic Factors
6%
Urinary Tract Infection
6%
Pennsylvania
6%
Single Port
6%
Lymph Node Metastasis
6%
Prostate Carcinoma
6%
Survival Outcomes
5%
Cisplatin
5%
Risk Stratification
5%
Complication Rate
5%
Operative
5%
Single-center Experience
5%
Urolithiasis
5%
Biochemical Recurrence
5%
Older Adults
5%
Tumor Stage
5%
Surgical Management
5%
Multivariate Analysis
5%
American Urological Association
5%
Pathologic
5%
Renal Tumor
5%
Upper Tract Urothelial Cancer
5%
Metastasis
5%
Cystectomy
5%